Invalidity dossier

US 4551862

Prosthetic sphincter

Current assignee: Habley Medical Technology Corp

Added 9/23/2026, 1:53:43 PM

At a glanceNo PTAB challengesNo litigation on file

Active provider: DeepSeek · deepseek-flash

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Patent Overview: US 4,551,862 — "Prosthetic Sphincter"

Bibliographic data (from supplied text): Application US06/435,761; filed 1982-12-15; granted and published 1985-11-12; inventor Terry M. Haber; original assignee "Individual"; assigned 1986-02-03 to Habley Medical Technology Corporation (a California corporation); status "Expired – Fee Related" with anticipated expiration 2002-12-15. Classification: A61F2/0036 (implantable devices constricting a lumen); cross-reference Y10S128/25 (artificial sphincters).

Purpose: The patent addresses incontinence by providing a prosthetic sphincter implantable without invading the elimination passage itself. It is intended to close the descending intestine or lower colon in a manner analogous to the normal sphincter muscle, and can be miniaturized for occluding a smaller-diameter pediatric urethra. The specification notes that devices placed on or just beneath the abdominal wall at a stoma are "unnatural" in location, whereas this device may sit at the anal-positioned end of the intestine, near the natural sphincter position.

Plain-language scope (from the definition and description): A stationary ring has an inward flange with a flat ledge and a circumferential spacer bead; a rotatable ring seats coaxially on that ledge, held concentric by the bead, which also provides a snapping and holding function. Occlusion spring means — described as individual elongated bendable elements (e.g., 15, 16, 17) fixed at first ends to the rotatable ring at 120° spaced points (18, 19, 20), their second ends terminating in small spheres (21, 22, 23) received in securement cavities (24–26) in the stationary ring — interconnect the two rings. Rotating the rotatable ring from a first to a second position drives the elements into the ring opening to occlude a passage about which the assembly is placed, holding occlusion until the ring is rotated back. Figures 1–8 depict exploded, assembled open/closed, cross-sectional, and modified embodiments, plus implantation across the large intestine and/or urethra.

Source: https://patents.google.com/patent/US4551862/en

Not established by this excerpt: the full claims and their exact wording; the complete specification (the text is marked "[Excerpt only]"); the detailed structure of the FIGS. 5–7 modified embodiments and the referenced "control means"; materials beyond passing mentions (silicone-containing polymers, metals); and any information on prior-art references, litigation, or ownership changes beyond the recorded assignment. No such matters are asserted here.

Generated 10/1/2026, 9:52:44 PM

Cases on file (0)

Specific litigation cases in our database that name US patent 4551862. The free-form analysis below may also discuss cases beyond this list.

No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Log in to generate
Not generated yet. Log in to request this analysis.

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Log in to generate
Not generated yet. Log in to request this analysis.

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Log in to generate
Not generated yet. Log in to request this analysis.

Prior art

Earlier patents, publications, and products that may anticipate or render the claims unpatentable.

Log in to generate
Not generated yet. Log in to request this analysis.

Obviousness

Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.

Log in to generate
Not generated yet. Log in to request this analysis.

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Log in to generate
Not generated yet. Log in to request this analysis.

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Log in to generate
Not generated yet. Log in to request this analysis.